Vaccines for measles, mumps, rubella, and varicella in children.
CONCLUSIONS: Existing evidence on the safety and effectiveness of MMR/MMRV vaccines support their use for mass immunisation. Campaigns aimed at global eradication should assess epidemiological and socioeconomic situations of the countries as well as the capacity to achieve high vaccination coverage. More evidence is needed to assess whether the protective effect of MMR/MMRV could wane with time since immunisation.
PMID: 32309885 [PubMed - in process]
Source: Cochrane Database of Systematic Reviews - Category: General Medicine Authors: Di Pietrantonj C, Rivetti A, Marchione P, Debalini MG, Demicheli V Tags: Cochrane Database Syst Rev Source Type: research
More News: Acute Leukemia | Asthma | Autism | Chickenpox | Children | Clinical Trials | Databases & Libraries | Dermatitis | Dermatology | Diabetes | Diabetes Type 1 | Disability | Eczema | Encephalitis | Endocrinology | Epidemiology | General Medicine | Hay Fever | Inflammatory Bowel Disease | Leukemia | Measles | Measles Vaccine | Men | Meningitis | Meningitis Vaccine | MMR (Measles,Mumps,Rubella) Vaccine | Multiple Sclerosis | Mumps | Mumps Vaccine | Respiratory Medicine | Rubella | Rubella Vaccine | Study | Vaccines
MedWorm Privacy Policy
Disclaimer
Copyright © MedWorm 2006-2024